RE:2 points to monitor in the next round of dataScienceFirst wrote
I don't expect many new patients treated since the Nov. 29 report, given the surge of Omicron early December to mid-January that might have slowed the recruitment/enrollment/treatment.
1) to see if the 90-days pending status of p#20-26 have all turned CR
2) if the « 70% (7/10) of CR at 90-days still CR at 180-days) » has turned « 70% (7/10) of CR at 90-days still CR at 270-days) »
If we hit good on these 2 points, then I think the odds of getting the next standard of care are becoming stronger and stronger statistically. We would then have a very stable and predictable treatment.
from this Master patient data tracker graciuousy provided by djdawg on Dec. 8. ScienceFirst the above data doesn't seem to correspond with my record of released information. I may be wrong but patient #20 hit the 90 day mark in Sept 2021 patients 21 to 23 should have also been included in the last set of data in Nov 29th newsletter. Patient 24 might not have been in that newsletter as #24 might have been at the cusp of 90 days. The newsletter of Nov. 29 showed the last treated group would've been patients 25 to 30 enrolled and provided the primary study treatment.